Angiotensin-(1-7) attenuates vasoconstriction evoked by angiotensin II but not by noradrenaline in man.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  HYPERTENSION

• Publication date

  2000-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.HYP.35.4.998PMID 10775575
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Vasodepressor actions of angiotensin-(1-7) unmasked during combined treatment with lisinopril and losartan.

  1998cited by this paper
• How reproducible is bilateral forearm plethysmography?

  1998cited by this paper
• Angiotensin-(1-7) contributes to the antihypertensive effects of blockade of the renin-angiotensin system.

  1998cited by this paper
• Angiotensin-(1-7) induces bradykinin-mediated hypotensive responses in anesthetized rats.

  1997cited by this paper
• Endogenous angiotensin II contributes to basal peripheral vascular tone in sodium deplete but not sodium replete man.

  1997cited by this paper
• Angiotensin-(1-7) augments bradykinin-induced vasodilation by competing with ACE and releasing nitric oxide.

  1997influential reference
• Angiotensin II and angiotensin-(1-7) effects on free cytosolic sodium, intracellular pH, and the Na(+)-H+ antiporter in vascular smooth muscle.

  1996cited by this paper
• Effects of captopril related to increased levels of prostacyclin and angiotensin-(1-7) in essential hypertension.

  1996cited by this paper
• Effects of captopril related to increased levels of prostacyclin and angiotensin-(1-7) in essential hypertension

  1996cited by this paper
• Angiotensin-(1-7) dilates canine coronary arteries through kinins and nitric oxide.

  1996cited by this paper
• Measuring forearm blood flow and interpreting the responses to drugs and mediators.

  1995cited by this paper
• Antihypertensive actions of angiotensin-(1-7) in spontaneously hypertensive rats.

  1995cited by this paper
• Pressor and reflex sensitivity is altered in spontaneously hypertensive rats treated with angiotensin-(1-7).

  1995cited by this paper
• Angiotensin-(1-7) potentiates the hypotensive effect of bradykinin in conscious rats.

  1995influential reference
• Release of nitric oxide by angiotensin‐(1–7) from porcine coronary endothelium: implications for a novel angiotensin receptor

  1994influential reference
• Angiotensin (1–7) is an antagonist at the type 1 angiotensin II receptor

  1994cited by this paper
• Cardiovascular actions of angiotensin(1-7).

  1993cited by this paper
• Angiotensin II/prostaglandin I2 interactions in spontaneously hypertensive rats.

  1993cited by this paper
• Subtype 2 Angiotensin Receptors Mediate Prostaglandin Synthesis in Human Astrocytes

  1991cited by this paper
• Effect of endothelium removal on the vasoconstrictor response to neuronally released 5‐hydroxytryptamine and noradrenaline in the rat isolated mesenteric and femoral arteries

  1991cited by this paper
• Endogenous nitric oxide modulates adrenergic neural vasoconstriction in guinea‐pig pulmonary artery

  1991cited by this paper
• Determinants of angiotensin II generation during converting enzyme inhibition.

  1990cited by this paper
• An alternative strategy for the radioimmunoassay of angiotensin peptides using amino-terminal-directed antisera: measurement of eight angiotensin peptides in human plasma.

  1990cited by this paper
• Processing of angiotensin peptides by NG108-15 neuroblastoma x glioma hybrid cell line.

  1990influential reference
• Prostaglandin production in response to angiotensin-(1-7) in rabbit isolated vasa deferentia.

  1990influential reference
• Identification of angiotensin-(1-7) in rat brain. Evidence for differential processing of angiotensin peptides.

  1989influential reference
• Endothelium-dependent modulation of angiotensin II-induced contraction in blood vessels.

  1988cited by this paper
• Biological activities of angiotensin II-(1-6)-hexapeptide and angiotensin II-(1-7)-heptapeptide in man.

  1986cited by this paper
• Failure sequence in solid-phase peptide synthesis due to the presence of an N-alkylamino acid.

  1972cited by this paper

• Gender-dependent renal hemodynamic responses to angiotensin 1–7 following AT1 receptor blockade and chronic renal denervation in rats

  2025cites this paper
• Counter-regulatory RAS peptides: new therapy targets for inflammation and fibrotic diseases?

  2024cites this paper
• Interplay of Angiotensin Peptides, Vasopressin, and Insulin in the Heart: Experimental and Clinical Evidence of Altered Interactions in Obesity and Diabetes Mellitus

  2024cites this paper
• Opiorphin: an endogenous human peptide with intriguing application in diverse range of pathologies

  2024cites this paper
• Angiotensin II type 1 receptor (AT1) blockade by Telmisartan attenuates hepatic steatosis in high-fat fed mice reducing Resistin, TRL4, and Myd88 expression

  2022cites this paper
• Counter-regulatory renin-angiotensin system in hypertension: Review and update in the era of COVID-19 pandemic

  2022cites this paper
• ACE2/Ang-(1-7)/Mas1 axis and the vascular system: vasoprotection to COVID-19-associated vascular disease

  2021cites this paper
• MicroRNA-130 a overexpression promotes proliferation , migration , and phenotypic modulation of vascular smooth muscle cells via enhancing phosphorylation of NF-κB p 65

  2019cites this paper
• Angiotensin-(1-7) and the Heart

  2019cites this paper
• Contributions by the Brain Renin-Angiotensin System to Memory, Cognition, and Alzheimer’s Disease

  2019cites this paper
• Angiotensin-(1-7): Translational Avenues in Cardiovascular Control.

  2019cites this paper
• Effects of angiotensin‐(1–7) and angiotensin II on vascular tone in human cirrhotic splanchnic vessels

  2018cites this paper
• Favorable Vascular Actions of Angiotensin-(1–7) in Human Obesity

  2018cites this paper
• The role of the angiotensin II type I receptor blocker telmisartan in the treatment of non-alcoholic fatty liver disease: a brief review

  2018cites this paper
• Effects of human opiorphin on food intake and water intake in mice following central administration.

  2017cites this paper
• Angiotensin-(1-7) regulates angiotensin II-induced matrix metalloproteinase-8 in vascular smooth muscle cells.

  2017cites this paper
• The Link Between Adipose Tissue Renin-Angiotensin-Aldosterone System Signaling and Obesity-Associated Hypertension.

  2017cites this paper
• Pharmacological significance of the interplay between angiotensin receptors: MAS receptors as putative final mediators of the effects elicited by angiotensin AT1 receptors antagonists.

  2015cites this paper
• Effects and underlying mechanisms of human opiorphin on cardiovascular activity in anesthetized rats.

  2015cites this paper
• A Direct Renin Inhibitor Aliskiren: Re-Evaluation of Effectiveness

  2015cites this paper
• Angiotensin-(1-7) as a strategy in the treatment of hypertension?

  2014cites this paper
• Angiotensin-(1–7) Modulates Angiotensin II-Induced Vasoconstriction in Human Mammary Artery

  2014cites this paper
• Hemodynamic responses to angiotensin-(1-7) in women in their third trimester of pregnancy

  2014cites this paper
• Mechanisms of vascular disease: divergent roles for suppressor of cytokine signaling 3 in angiotensin II-induced vascular dysfunction

  2014cites this paper
• Angiotensin (1-7) counteracts the negative effect of angiotensin II on insulin signalling in HUVECs.

  2013cites this paper
• Angiotensin-(1-7) regulates Angiotensin II-induced VCAM-1 expression on vascular endothelial cells.

  2013cites this paper
• Pharmacological potential of exercise and RAS vasoactive peptides for prevention of diseases.

  2013cites this paper
• A Systematic Review to Investigate Whether Angiotensin-(1-7) Is a Promising Therapeutic Target in Human Heart Failure

  2013cites this paper
• Angiotensin-(1–7)–Induced Renal Vasodilation in Hypertensive Humans Is Attenuated by Low Sodium Intake and Angiotensin II Co-Infusion

  2013cites this paper
• Update on new aspects of the renin-angiotensin system in liver disease: clinical implications and new therapeutic options.

  2012cites this paper
• Angiotensin‐(1‐7) inhibits epidermal growth factor receptor transactivation via a Mas receptor‐dependent pathway

  2012cites this paper
• Angiotensin-(1-7) upregulates central nitric oxide synthase in spontaneously hypertensive rats.

  2012cites this paper
• Regulation of angiotensin-converting enzyme 2 and Mas receptor by Ang-(1–7) in heart and kidney of spontaneously hypertensive rats

  2011cites this paper
• Cyclooxygenase mediates cardioprotection of angiotensin-(1-7) against ischemia/reperfusion-induced injury through the inhibition of oxidative stress.

  2011cites this paper
• Étude de la protection vasculaire par l’angiotensine IV : rôle dans le diabète et le traumatisme crânien

  2011cites this paper
• ELIZABETH PORTUGAL PIMENTA VELLOSO

  2011cites this paper
• Different Effects of Angiotensin II and Angiotensin-(1-7) on Vascular Smooth Muscle Cell Proliferation and Migration

  2010cites this paper
• Angiotensin-(1-7) improves cardiac remodeling and inhibits growth-promoting pathways in the heart of fructose-fed rats.

  2010cites this paper
• Physiology of kidney renin.

  2010cites this paper
• Angiotensin-(1-7) and low-dose angiotensin II infusion reverse salt-induced endothelial dysfunction via different mechanisms in rat middle cerebral arteries.

  2010cites this paper
• Novel neurohormonal insights with therapeutic potential in chronic heart failure.

  2010cites this paper
• Angiotensin-(1-7) upregulates cardiac nitric oxide synthase in spontaneously hypertensive rats.

  2010cites this paper
• Regulation of Kinin Receptor Expression in Heart Failure with a Focus on Vascular Endothelium

  2010cites this paper
• INVOLVEMENT OF PROLYLCARBOXYPEPTIDASE IN THE EFFECT OF RUTAECARPINE ON THE REGRESSION OF MESENTERIC ARTERY HYPERTROPHY IN RENOVASCULAR HYPERTENSIVE RATS

  2009cites this paper
• [Angiotensin (1-7): a new link in the renin-angiotensin-aldosterone system (RAAS)].

  2009cites this paper
• Angiotensin II Relaxations of Bovine Adrenal Cortical Arteries: Role of Angiotensin II Metabolites and Endothelial Nitric Oxide

  2008cites this paper
• Unraveling the Complexities of the Renin-Angiotensin System: From ACE to renin inhibition

  2008cites this paper
• Effects of angiotensin II and its metabolites in the rat coronary vascular bed: is angiotensin III the preferred ligand of the angiotensin AT2 receptor?

  2008cites this paper
• Drug-induced burning mouth syndrome: a new etiological diagnosis.

  2008cites this paper
• Angiotensin receptor subtype mediated physiologies and behaviors: new discoveries and clinical targets.

  2008cites this paper
• Phosphoinositide hydrolysis increase by angiotensin-(1--7) in neonatal rat brain.

  2007cites this paper
• Effects of angiotensin 1-7 on the actions of angiotensin II in the renal and mesenteric vasculature of hypertensive and streptozotocin-induced diabetic rats.

  2007cites this paper
• Role of the vasodilator peptide angiotensin-(1–7) in cardiovascular drug therapy

  2007influential citation
• ACE2 of the heart: From angiotensin I to angiotensin (1-7).

  2007cites this paper
• Angiotensin-Converting Enzyme and Vascular Remodeling

  2007cites this paper
• An update on non-peptide angiotensin receptor antagonists and related RAAS modulators.

  2007cites this paper
• Evidence for a new angiotensin-(1-7) receptor subtype in the aorta of Sprague-Dawley rats.

  2007cites this paper
• Vasomodulatory actions of des-asp-angiotensin I and angiotensin 1-7 in resistance vessels of hypertensive and diabetic rat models

  2007influential citation
• Influência do polimorfismo do gene da ECA e do angiotensinogênio na hipertrofia miocárdica e melhora da capacidade funcional provocados pelo treinamento físico

  2007cites this paper
• Angiotensin-Converting Enzyme and Vascular Remodeling

  2007cites this paper
• Different responses to angiotensin-(1-7) in young, aged and diabetic rabbit corpus cavernosum.

  2007cites this paper
• Effect of hypertension on angiotensin-(1-7) levels in rats with different angiotensin-I converting enzyme polymorphism.

  2006cites this paper
• The therapeutic potential of Angiotensin-(1-7) as a novel Renin-Angiotensin System mediator.

  2006cites this paper
• Potential of gene therapy strategy for the treatment of hypertension.

  2006cites this paper
• Pressor responses to alligator Angiotensin I and some analogs in the spectacled caiman (Caiman crocodilus).

  2006cites this paper
• Olmesartan Is an Angiotensin II Receptor Blocker with an Inhibitory Effect on Angiotensin-Converting Enzyme

  2006influential citation
• ACE2: A novel therapeutic target for cardiovascular diseases.

  2006cites this paper
• Angiotensins in Brain Function

  2006cites this paper
• Chronic administration of angiotensin-(1-7) attenuates pressure-overload left ventricular hypertrophy and fibrosis in rats.

  2005cites this paper
• Therapeutic perspectives of Angiotensin-(1-7) in heart failure

  2005cites this paper
• The suitability of iodinated Angiotensin-(1-7) peptides as pharmacological tools.

  2005cites this paper
• Chronic infusion of angiotensin-(1-7) reduces heart angiotensin II levels in rats.

  2005cites this paper
• Angiotensin‐converting enzyme 2 as a novel target for gene therapy for hypertension

  2005cites this paper
• Selective Angiotensin-Converting Enzyme C-Domain Inhibition Is Sufficient to Prevent Angiotensin I–Induced Vasoconstriction

  2005cites this paper
• The Endothelium-Dependent Vasodilator Effect of the Nonpeptide Ang(1-7) Mimic AVE 0991 Is Abolished in the Aorta of Mas-Knockout Mice

  2005cites this paper
• Angiotensin-(1-7) modulates vascular resistance and sympathetic neurotransmission in kidneys of spontaneously hypertensive rats.

  2004cites this paper
• Angiotensin-(1-7) inhibits the angiotensin II-enhanced norepinephrine release in coarcted hypertensive rats.

  2004cites this paper
• Angiotensin-(1–7). Its Contribution to Arterial Pressure Control Mechanisms

  2004cites this paper
• Newly recognized components of the renin-angiotensin system: potential roles in cardiovascular and renal regulation.

  2003cites this paper
• Angiotensin-(1–7) is an endogenous ligand for the G protein-coupled receptor Mas

  2003cites this paper
• Effects of angiotensin-(1-7) and other bioactive components of the renin–angiotensin system on vascular resistance and noradrenaline release in rat kidney

  2003cites this paper
• Biphasic effects of angiotensin (1-7) and its interactions with angiotensin II in rat aorta

  2003cites this paper
• Systemic and regional hemodynamic effects of angiotensin-(1-7) in rats.

  2003cites this paper
• New Aspects of Ace Inhibition: Importance of ACE co-localization with angiotensin and bradykinin receptors

  2003influential citation
• Bradykinin, angiotensin-(1-7), and ACE inhibitors: how do they interact?

  2003cites this paper
• Procédé de préparation de formulations de la peptide angiotensine-(1-7) et de ses analogues, agonistes et antagonistes au moyen de cyclodextrines, liposomes et polymères biodégradables et/ou des mélanges et des produits correspondants

  2002cites this paper
• Angiotensin-(1-7) Inhibits Angiotensin II–Induced Signal Transduction

  2002cites this paper
• Renal microvascular actions of angiotensin II fragments.

  2002cites this paper
• Angiotensin-(1-7): an active member of the renin-angiotensin system.

  2002cites this paper
• AVE 0991, a Nonpeptide Mimic of the Effects of Angiotensin-(1–7) on the Endothelium

  2002cites this paper
• ACEH/ACE2 is a novel mammalian metallocarboxypeptidase and a homologue of angiotensin-converting enzyme insensitive to ACE inhibitors.

  2002cites this paper
• Angiotensin(1–7) potentiates bradykinin-induced vasodilatation in man

  2001cites this paper
• Angiotensin-(1-7) Does Not Affect Vasodilator or TPA Responses to Bradykinin in Human Forearm

  2001cites this paper
• Bradykinin Potentiation by Angiotensin-(1-7) and ACE Inhibitors Correlates With ACE C- and N-Domain Blockade

  2001influential citation
• Interactions between angiotensin-(1-7), kinins, and angiotensin II in kidney and blood vessels.

  2001cites this paper
• Effects of Angiotensin-(1-7) on Forearm Circulation in Normotensive Subjects and Patients With Essential Hypertension

  2001cites this paper
• Angiotensin-(1-7) Downregulates the Angiotensin II Type 1 Receptor in Vascular Smooth Muscle Cells

  2001cites this paper
• Effects of angiotensin IV and angiotensin-(1-7) on basal and angiotensin II-stimulated cytosolic Ca2+ in mesangial cells.

  2001cites this paper
• Downregulation of the AT1A Receptor by Pharmacologic Concentrations of Angiotensin-(1-7)

  2001cites this paper
• Angiotensin-(1-7): an update.

  2000cites this paper